Indian government tasks the Indian Pharmacopoeia Commission (IPC) with proactive drug safety monitoring to align pharmacovigilance with global norms.
7 reports, 3 independent
Updated Sep 21
Gone quiet
- Reports
- 7
- Developments
- 4
- Repetition
- 71%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Indian government tasks the Indian Pharmacopoeia Commission (IPC) with proactive drug safety monitoring to align pharmacovigilance with global norms.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- The Ministry of Health and Family Welfare approved a Biovigilance Programme on September 21, 2026.Sub-event
IPC releases 7th edition of NFI, prioritizing patient safety.1 source
- The All India Organisation of Chemists & Druggists urges the government to reconsider the existing surveillance mandate.Sub-event
Indian government mandates IPC to align pharmacovigilance with global standards.1 source
Keep exploring
The entities involved
-
Indian Pharmacopoeia Commission
Indian pharmacopoeia 9335
Nothing else this week.
-
World Health Organization
United Nations agency concerned with international public health